ImmunologybioRxiv
Kasugamycin is a novel chitinase 1 inhibitor with strong antifibrotic effects on pulmonary fibrosis
J.-H. Lee, C.-M. Lee, J. H. Lee…·C. G. Lee
This study identifies Kasugamycin as a novel CHIT1 inhibitor with strong antifibrotic effects in pulmonary fibrosis models.
DOI 10.1165/rcmb.2021-0156oc